Please try another search
Isracann Biosciences Inc. reported earnings results for the first quarter ended August 31, 2022. For the first quarter, the company reported net loss was CAD 0.315995 million compared to CAD 0.468842 million a year ago. Basic loss per share from continuing operations was CAD 0.002 compared to CAD 0.003 a year ago.
Period Ending: | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 |
---|---|---|---|---|
Total Revenue | 0 | 0 | ||
Gross Profit | ||||
Operating Income | -0.288 | -0.59 | -0.9 | |
Net Income | -0.316 | -0.62 | -0.87 |
Period Ending: | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 |
---|---|---|---|---|
Total Assets | 4.04 | 4.09 | 2.78 | 3.41 |
Total Liabilities | 3.91 | 3.8 | 0.74 | 0.77 |
Total Equity | 0.125 | 0.29 | 2.04 | 2.64 |
Period Ending: | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 9 Months | 0 Months |
Cash From Operating Activities | -0.163 | -1.54 | -1.02 | |
Cash From Investing Activities | -0.12 | -0.12 | ||
Cash From Financing Activities | 0.152 | 0 | 0 | |
Net Change in Cash | -0.016 | -1.65 | -1.13 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review